Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSThree Regulatory News (STEM)

Share Price Information for SThree (STEM)

Share Price is delayed by 15 minutes
Get Live Data
170.20    -0.20 (-0.12%)
Bid:
170.40
Ask:
171.00
Spread: 0.60 (0.352%)
Market Cap: £208.86m
STEM Live PriceLast checked at - London Stock Exchange

Intraday SThree Share Chart

Directorate Change

2 Apr 2024 12:10

RNS Number : 9781I
SThree plc
02 April 2024
 

2 April 2024

 

SThree plc

 

Directorate Change

 

SThree plc, the only global specialist talent partner focused on roles in Science, Technology, Engineering and Mathematics (STEM), is pleased to announce that it will appoint Sanjeevan Bala as an Independent Non-Executive Director with effect from the conclusion of the Annual General Meeting on 25 April 2024, in line with its previously stated plan to recruit a new Non-Executive.

 

Sanjeevan has extensive experience driving customer-centric technology transformation, having most recently been responsible for driving the digital data and AI transformation of the UK's largest commercial broadcaster and media company, ITV plc as the Group Chief Data and AI Officer. Prior to this, Sanjeevan was Head of Data Science at Channel 4 and held senior roles at Clear Cell Group and Dunhumby, a global leader in Customer Data Science.

 

Sanjeevan is currently a Non-Executive Director and the Designated Workforce Engagement NED at Bakkavor Group plc, Co-Chair of the Chief Data and AI Office Board at Evanta, a Gartner Company and on the Advisory Board of DataIQ.

 

On joining the Board, Sanjeevan will also be appointed as a member of the Audit & Risk, Nominations and Remuneration Committees.

 

James Bilefield, Chairman, commented: 

 

"I am delighted to welcome Sanjeevan to SThree and the Board. Sanjeevan is a highly experienced multi award-winning data and analytics professional with a proven track record of driving customer-centric business transformations through the strategic use of data. He brings with him extensive strategic and commercial experience which will be particularly relevant as we continue to roll out our Technology Improvement Programme, positioning us as game-changers in the market and demonstrating our ambition to be digital-first innovators. We look forward to working with him as the Group continues to execute its growth strategy."

 

 

Sanjeevan Bala commented:

 

"Having spent most of my career in STEM and witnessing first-hand the global demand for these skills expand exponentially, it feels like an incredibly exciting time to be joining SThree. The SThree team talks to global megatrends that underpin the demand for STEM and flexible talent and they couldn't be more correct. I look forward to working with the Board and forward-thinking leadership team to capitalise on this structural opportunity."

 

Notes:

This disclosure is given in accordance with LR 9.6.11 R of the Listing Rules. There is no further information to be disclosed pursuant to Listing Rule 9.6.13. 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAUPUAUCUPCGGP
Date   Source Headline
2nd Sep 20242:30 pmRNSChange of Registered Office
2nd Sep 202410:51 amRNSTotal Voting Rights
23rd Aug 202411:00 amRNSBlock listing Interim Review
12th Aug 20242:00 pmRNSDirector/PDMR Shareholding
1st Aug 202411:30 amRNSTotal Voting Rights
23rd Jul 20245:31 pmRNSDirector/PDMR Shareholding
23rd Jul 20247:01 amRNSNotice of Investor Briefing
23rd Jul 20247:00 amRNSFY24 Half Year Results
16th Jul 20247:00 amRNSNotice of Third Investor Briefing
12th Jul 20243:30 pmRNSDirector/PDMR Shareholding
1st Jul 202411:42 amRNSTotal Voting Rights
18th Jun 20247:00 amRNSFY24 Half Year Trading Update
13th Jun 20241:26 pmRNSDirector/PDMR Shareholding
11th Jun 20242:35 pmRNSDirector/PDMR Shareholding
3rd Jun 20249:50 amRNSTotal Voting Rights
13th May 20244:00 pmRNSDirector/PDMR Shareholding
25th Apr 202411:44 amRNSResult of AGM
15th Apr 20243:48 pmRNSDirector/PDMR Shareholding
10th Apr 202412:14 pmRNSChange of Auditor
2nd Apr 202412:10 pmRNSDirectorate Change
22nd Mar 20244:29 pmRNSDirector/PDMR Shareholding
19th Mar 20243:30 pmRNSDirector/PDMR Shareholding
19th Mar 20247:00 amRNSFY24 Q1 Trading Update
14th Mar 202412:11 pmRNSDirector/PDMR Shareholding
12th Mar 20243:59 pmRNSDirector/PDMR Shareholding
7th Mar 20249:20 amRNSDirector/PDMR Shareholding
4th Mar 202410:54 amRNSAnnual Financial Report
23rd Feb 20242:00 pmRNSBlock listing Interim Review
13th Feb 20244:45 pmRNSDirector/PDMR Shareholding
1st Feb 202410:20 amRNSTotal Voting Rights
30th Jan 20247:00 amRNSFY23 Final Results
23rd Jan 20244:25 pmRNSChange of Registrar
15th Jan 20241:19 pmRNSDirector/PDMR Shareholding
18th Dec 20234:56 pmRNSDirector/PDMR Shareholding
14th Dec 202310:58 amRNSDirector/PDMR Shareholding
14th Dec 20237:00 amRNSFY23 Full Year Trading Update
8th Dec 20234:30 pmRNSDirectorate Change
1st Dec 20232:27 pmRNSTotal Voting Rights
23rd Nov 20237:00 amRNSAppointment of Joint Corporate Brokers
16th Nov 202312:41 pmRNSDirector/PDMR Shareholding
14th Nov 20239:45 amRNSHolding(s) in Company
2nd Nov 20232:45 pmRNSTotal Voting Rights
16th Oct 20232:02 pmRNSDirector/PDMR Shareholding
2nd Oct 20233:53 pmRNSTotal Voting Rights
20th Sep 20231:19 pmRNSDirector/PDMR Shareholding
19th Sep 20237:00 amRNSFY23 Q3 Trading Update
13th Sep 202310:35 amRNSDirector/PDMR Shareholding
1st Sep 202312:17 pmRNSTotal Voting Rights
23rd Aug 202311:40 amRNSBlock listing Interim Review
16th Aug 20232:16 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.